SURMOUNT ‐ REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity

Journal article

Objective: SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods: A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through access to participants' integrated electronic healthcare record data. The study will enroll approximately 3000 participants from Greater Manchester, UK, who are randomly assigned in a 1:1 ratio to receive either tirzepatide and SoC or SoC alone. Results: The primary endpoint is the percent change in body weight from baseline to Month 24, with the time to onset of type 2 diabetes to Month 60 being the key secondary endpoint. Additional endpoints include the impact of tirzepatide versus SoC on obesity‐related complications, health‐related quality of life, healthcare resource utilization, productivity, employment, and sickness‐related absences. Conclusions: SURMOUNT‐REAL UK employs a novel study design to evaluate real‐world health outcomes and potential long‐term benefits for both participants and the healthcare system associated with the delivery of pharmacological obesity treatment at a population level. The study is intended to generate critical evidence to support informed decision‐making in obesity management, clinical guideline development, and healthcare policy. Trial Registration: ClinicalTrials.gov identifier: NCT07247084

Authors: Rutter, MK; Mount, J; Gibson, JM; Webb, J; Marler, C

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Wiley
• Journal: Obesity
• Article number: oby.70247
• Publication date: 2026-06-15
• Acceptance date: 2026-05-18
• DOI: 10.1002/oby.70247
• EISSN: 1930-739X
• ISSN: 1930-7381
• Language: English
• Keywords: obesity; type 2 diabetes incidence; electronic health records; pragmatic trial; primary care